Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Interventional, Post-Market-Clinical-Follow up (PMCF), Prospective, Open-Label, Single-Center Observational Study Evaluating Croma Revitalis in Correction of Fine Lines

NCT07492277 is registered in ClinicalTrials.gov with Croma-Pharma GmbH as lead sponsor.

NCT NCT07492277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07492277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Interventional, Post-Market-Clinical-Follow up (PMCF), Prospective, Open-Label, Single-Center Observational Study Evaluating Croma Revitalis in Correction of Fine Lines
Lead sponsor
Croma-Pharma GmbH
Phase
Observational
Overall status
Active, not recruiting
Start date
January 16, 2026
Completion date
September 30, 2026
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lateral canthal lines (lcl), perioral rhytids